bmiMD vs Priority Meds
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Priority Meds
Best for pending product verificationStarting at $113/mo
Side-by-Side Comparison
| Feature | bmiMD | Priority Meds |
|---|---|---|
| Overall Score | 7.1/10 | 7.1/10 |
| Starting Price | — | $113/mo |
| Editorial Rating | 3.6 ★ /5 | 3.6 ★ /5 |
| Features | 2 features | ✓4 features |
| States Available | ✓50 | 0 |
| Compounded | — | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
bmiMD
Pros
- ✓Both semaglutide and tirzepatide available
Cons
- ✗Pricing not publicly disclosed
Priority Meds
Pros
- ✓Flat-dose pricing (no dose-escalation increases) per competitor sources
- ✓B-vitamin co-compounding (sema+B12, tirz+B6) is a differentiator in the segment
- ✓Clearwater FL based US operation
Cons
- ✗Stub entry — exact drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
- ✗Confidence is LOW until that pass is done
Our Verdict
Both bmiMD and Priority Meds score equally well overall — the right choice depends on your priorities. Choose bmiMD if you want mainstream telehealth GLP-1 access, or Priority Meds if pending product verification matters most to you.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.